Gabapentin vs Vyepti
A side-by-side look at two neurology medications advertised on TV. Informational only — not medical advice.
| US Gabapentin | US Vyepti | |
|---|---|---|
| Generic name | gabapentin | eptinezumab |
| Drug class | Anticonvulsant / Nerve Pain Agent | Anti-CGRP Monoclonal Antibody |
| Treats | Nerve pain, seizures | Migraine prevention |
| Category | Neurology | Neurology |
| Manufacturer | Various (generic) | Lundbeck |
| Year approved | 1993 | 2020 |
| FDA warning | Moderate warnings | No boxed warning |
| Est. TV ad spend | $1M | — |
| Common side effects | Drowsiness, Dizziness, Swelling, Coordination problems | Stuffy nose and sore throat, Allergic reactions, Fatigue |
Gabapentin
Frequently asked questions
Is Gabapentin or Vyepti better?
Neither is universally "better." Gabapentin (gabapentin) and Vyepti (eptinezumab) are both used for neurology, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Gabapentin and Vyepti?
Gabapentin is a Anticonvulsant / Nerve Pain Agent made by Various (generic), while Vyepti is a Anti-CGRP Monoclonal Antibody made by Lundbeck. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Gabapentin has the larger estimated TV advertising budget of the two.